IRIS
ORLANDI, ESTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.862
AS - Asia 1.813
EU - Europa 965
SA - Sud America 277
AF - Africa 73
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.994
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.759
SG - Singapore 555
CN - Cina 440
HK - Hong Kong 348
RU - Federazione Russa 255
VN - Vietnam 225
BR - Brasile 194
DE - Germania 150
FR - Francia 132
IT - Italia 112
GB - Regno Unito 91
IE - Irlanda 65
IN - India 60
MX - Messico 54
FI - Finlandia 40
ZA - Sudafrica 37
CA - Canada 34
AR - Argentina 32
BD - Bangladesh 30
JP - Giappone 29
PL - Polonia 22
TR - Turchia 21
AT - Austria 17
IQ - Iraq 17
SE - Svezia 16
BE - Belgio 14
CO - Colombia 14
PK - Pakistan 12
ID - Indonesia 10
VE - Venezuela 10
EC - Ecuador 9
ES - Italia 9
NL - Olanda 8
SA - Arabia Saudita 8
IL - Israele 7
TN - Tunisia 7
CL - Cile 6
DZ - Algeria 6
JO - Giordania 6
UA - Ucraina 6
EG - Egitto 5
JM - Giamaica 5
LV - Lettonia 5
MY - Malesia 5
PH - Filippine 5
PY - Paraguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
KE - Kenya 4
MA - Marocco 4
AU - Australia 3
AZ - Azerbaigian 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
QA - Qatar 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 4.994
Salva come PNG Salva come JPEG
Città #
Dallas 496
Hong Kong 337
San Jose 292
Singapore 259
Ashburn 147
Beijing 131
Lauterbourg 93
Ho Chi Minh City 73
Los Angeles 70
Dublin 65
Redondo Beach 65
Hanoi 59
Munich 50
Moscow 44
Falkenstein 40
Mexico City 38
Chandler 35
Buffalo 32
Santa Clara 32
New York 31
Johannesburg 30
Pavia 25
Tokyo 25
Shanghai 24
Montreal 22
Orem 22
Helsinki 21
São Paulo 21
Warsaw 20
Council Bluffs 19
Boardman 18
Milan 17
London 16
Turku 16
Atlanta 15
Frankfurt am Main 15
Secaucus 15
Brooklyn 14
Nuremberg 14
Brussels 13
Changsha 13
Stockholm 13
Chennai 11
Da Nang 11
Denver 11
Haiphong 11
Boston 10
Chicago 10
Seattle 10
Düsseldorf 9
Princeton 9
Belo Horizonte 8
Dhaka 8
Lawrence 8
Manchester 8
Medford 8
Ankara 7
Charlotte 7
Guangzhou 7
Phoenix 7
Amman 6
Ann Arbor 6
Baghdad 6
Elk Grove Village 6
Hyderabad 6
Istanbul 6
Nanjing 6
Poplar 6
Rio de Janeiro 6
Vienna 6
Wilmington 6
Brasília 5
Buccinasco 5
Bến Tre 5
Florence 5
Guayaquil 5
Hải Dương 5
Jacksonville 5
Medellín 5
Mumbai 5
Paris 5
Porto Alegre 5
Riga 5
Riyadh 5
San Francisco 5
Tashkent 5
Turin 5
Addis Ababa 4
Amsterdam 4
Houston 4
Kingston 4
Nanchang 4
New Delhi 4
Phủ Lý 4
Rozzano 4
Tianjin 4
Wuhan 4
Yiwu 4
Aubergenville 3
Baku 3
Totale 3.153
Salva come PNG Salva come JPEG
Nome #
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area 298
Intravoxel incoherent motion as a tool to detect early microstructural changes in meningiomas treated with proton therapy 99
Cancer Rehabilitation and Physical Activity: the "Oncology in Motion" Project 90
Contouring of the Pharyngeal Superior Constrictor Muscle (PSCM). A cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group 89
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 88
Radiomics and dosiomics for predicting local control after carbon-ion radiotherapy in skull-base chordoma 85
Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations 80
Using the photon isoeffective dose formalism to compare and combine BNCT and CIRT in a head and neck tumour 79
To a new normal in radiation oncology: looking back and planning forward 79
Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy 78
Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? 76
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 73
Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy 72
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 71
Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation 69
NR4A3 fusion molecular profile change pathological diagnosis? A case report 65
Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review 64
Charged particle radiotherapy for thyroid cancer. A systematic review 62
Evaluation of endocrinological sequelae following particle therapy performed on anterior skull base lesions in the adult population 61
A Patient Selection Approach Based on NTCP Models and DVH Parameters for Definitive Proton Therapy in Locally Advanced Sinonasal Cancer Patients 60
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review 60
Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation 58
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm? 57
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients 56
The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment 55
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) 55
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC) 53
Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936) 52
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 52
Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy 51
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? 51
A Dosiomics Analysis Based on Linear Energy Transfer and Biological Dose Maps to Predict Local Recurrence in Sacral Chordomas after Carbon-Ion Radiotherapy 51
Baseline MRI-radiomics can predict overall survival in non endemic nasopharyngeal cancer patients 51
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group 50
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 49
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 49
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 48
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 48
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 48
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 47
Are there any dosimetric predictors of acute toxicity during RT for NPC that can be modulated by genetic risk factors? 46
Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy? 45
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients 45
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 45
Neutron brachytherapy in the modern era: Indications and evidence 45
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients 45
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 42
Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC) 42
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 42
Sexual Health Dysfunction After Radiotherapy for Gynecological Cancer: Role of Physical Rehabilitation Including Pelvic Floor Muscle Training 42
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 42
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 42
Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed 41
The Role of Carbon Ion Therapy in the Changing Oncology Landscape—A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy 40
An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia 40
Resection of the internal carotid artery in selected patients affected by cancer of the skull base 40
Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era 40
How can we address the challenge of distant metastases in HNSCC prognosis? 39
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 38
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 38
Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series 37
Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations 36
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 36
The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer: Inter-fraction robustness in CIRT for pancreatic cancer 36
Moderately accelerated intensity-modulated radiation therapy using simultaneous integrated boost: Practical reasons or evidence-based choice? A critical appraisal of literature 35
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 35
Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma 35
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 34
Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision 34
Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity 34
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group 33
Current management and future challenges in salivary glands cancer 33
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 33
A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 33
Towards a European prospective data registry for particle therapy 32
How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy: RBE and LET in carbon ion therapy for sacral chordoma 32
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 32
Current practice in proton therapy delivery in adult cancer patients across Europe 31
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 31
Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation 31
Patterns of Failure after Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy for Patients with Nasopharyngeal Carcinoma 31
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy 30
INDUCTION CHEMOTHERAPY WITHIN A MULTIMODALITYREATMENT OF NASAL CAVITY AND ETHMOID SINUS MALIGNANT EPITHELIAL TUMOURS: REPORT OF AN HOMOGENEOUS SERIES OF PATIENTS 30
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 29
The MUSES∗: a prognostic study on 1360 patients with sinonasal cancer undergoing endoscopic surgery-based treatment 29
Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram 29
Particle Radiotherapy for Skull Base Chondrosarcoma: A Clinical Series from Italian National Center for Oncological Hadrontherapy 29
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences? 29
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design 29
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 29
Repeatability and reproducibility of MRI‐radiomic features: A phantom experiment on a 1.5 T scanner 28
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 28
Quality of life changes over time and predictors in a large head and neck patients’ cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study—a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 28
Radiotherapy and Medical Treatment 28
Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO 28
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS 27
Synthetic CT in Carbon Ion Radiotherapy of the Abdominal Site 27
Repeatability and reproducibility of MRI-radiomic features: A phantom experiment on a 1.5 T scanner 26
Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review 25
Management of loco-regionally advanced squamous laryngeal cancer in elderly patients 25
Totale 4.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.085
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 1 0
2021/202243 0 1 0 3 0 2 1 3 4 3 4 22
2022/2023153 16 9 4 5 4 13 15 4 67 1 9 6
2023/2024107 8 9 3 8 7 14 6 16 3 2 19 12
2024/20251.345 11 25 10 10 10 103 211 116 318 56 107 368
2025/20263.439 265 555 287 409 387 130 587 174 368 277 0 0
Totale 5.116